The emerging therapy of tirzepatide peptide represents a significant development in the care of the condition. Unlike existing therapies, tirzepatide affects two pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) – leading to improved sugar control and anticipated weight reduction. Experts are investigating its long-term be… Read More